This is an abstract of the document. To keep reading, click here and get access to the original version. AttachmentsOriginal document Permalink. Disclaimer. Datadog Inc ... (noodl. 134639977) .
Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract CancerFollowingFDAFeedback The FDA recommended that Compass conduct a trial to demonstrate a survival benefit prior to submitting a BLA for tovecimig.
After finding little change in the number of adverse actions taken against federal employees, the Office of Personnel Management is now looking for more feedback on how to “appropriately incentivize” federal managers to take action.